Influence of statin therapy on exacerbation frequency in patients with COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
Effect of ICS withdrawal on COPD exacerbations in patients on triple therapy at baseline Source: International Congress 2018 – COPD management Year: 2018
The effect of tiotropium/olodaterol versus tiotropium on COPD exacerbation rates in patients with/without frequent exacerbation history Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019
Phenotype-based therapy of COPD: Effect on the rate of COPD exacerbations Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018
Influence of tiotropium bromide on quantity of exacerbations and survival rate of COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 74s Year: 2007
Effect of roflumilast on exacerbations in patients with severe COPD and a prior history of hospitalization taking combination therapy Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015
Formoterol given either alone or together with tiotropium, reduces the rate of exacerbations in stable COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 430s Year: 2006
Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study Source: Eur Respir J, 50 (4) 1700711; 10.1183/13993003.00711-2017 Year: 2017
Determinants of exacerbation rate in patients with stable COPD Source: Eur Respir J 2004; 24: Suppl. 48, 661s Year: 2004
Duration of systemic corticosteroids treatment in COPD exacerbations Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008
Effect of roflumilast on hospitalizations in COPD patients Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012
Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
Decaf score for predicting treatment escalation in exacerbations of COPD Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020
Six months azithromycin treatment in COPD patients with high risk of further exacerbations Source: International Congress 2017 – Management of COPD Year: 2017
The direct costs of exacerbations in COPD and the effect of cilomilast treatment Source: Eur Respir J 2002; 20: Suppl. 38, 245s Year: 2002
Effect of roflumilast in patients with severe COPD and a history of hospitalisation Source: Eur Respir J, 50 (1) 1700158; 10.1183/13993003.00158-2017 Year: 2017
Long-term effect of roflumilast on exacerbations in patients with severe to very severe COPD Source: Eur Respir J 2006; 28: Suppl. 50, 526s Year: 2006
Tiotropium reduces the risk of COPD exacerbation irrespective of its characterization by the treatment intervention Source: Eur Respir J 2006; 28: Suppl. 50, 764s Year: 2006
The 1-year cost-effectiveness of roflumilast for the treatment of severe to very severe COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 194s Year: 2007
Efficiency of therapy of COPD exacerbations and 1-year survival rate after hospitalization Source: Eur Respir J 2007; 30: Suppl. 51, 556s Year: 2007